Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
about
Gene doping: gene delivery for olympic victoryRegenerative therapies for diabetic microangiopathyGlucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing.Dose-dependent neovascularization-promoting effect of adenovirus vector CI-1023 in a rat hindlimb ischaemic model.Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive diseaseGene therapy: design and prospects for craniofacial regeneration.Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits.Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.Gene therapy of monogenic and cardiovascular disorders.Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats.Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis.Acceleration of bone-defect repair by using A-W MGC loaded with BMP2 and triple point-mutant HIF1α-expressing BMSCs.Therapeutic angiogenesis for myocardial ischemia.Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease.Therapeutic angiogenesis using vascular endothelial growth factor.Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets.Myocardial therapeutic angiogenesis: a review of the state of development and future obstaclesIn vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs.Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function.Pharmacologic therapy for intermittent claudication.Extracorporeal shock wave therapy for ischemic cardiovascular disorders.Angiogenic growth factors in myocardial infarction: a critical appraisal.Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing.The HIF-1 response to simulated ischemia in mouse skeletal muscle cells neither enhances glycolysis nor prevents myotube cell death.Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia.Angiogenic potency evaluation of cell therapy candidates by a novel application of the in vitro aortic ring assay.(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels.Triple point-mutants of hypoxia-inducible factor-1α accelerate in vivo angiogenesis in bone defect regions.A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium.A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia.The role of vascular endothelial growth factor in wound healing.Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo.The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro.Prevention of distal flap necrosis in a rat random skin flap model by gene electro transfer delivering VEGF(165) plasmid.Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.
P2860
Q26995443-F4BC7C18-10BA-4F02-90BA-7560B7329008Q27027852-3E578B20-B978-4F7A-9E82-C04834536290Q30428132-76CE8746-527A-40B0-A73C-14E6C4FFF8DAQ31114069-E628208F-9ADC-48E9-8DB0-9FF98DF29D4AQ33241243-80D67EE7-F26A-4918-B589-344F8AF9946BQ33833050-0FE5C072-D2CB-4890-85CC-0D8D618200C6Q34007347-3A775499-E230-49DF-8CF6-FD76531EEE62Q34429250-84F85031-3418-468B-BB83-3D0CBE55FB39Q34479397-C78928FC-8430-4914-A9ED-8393D0F8DC50Q35207521-4370C869-7282-4199-8247-E3284843043DQ35397286-904EF402-69A6-4576-A38B-7013EF6E184EQ35544526-6023366F-D573-473D-960A-0AFAD2C2CF78Q35670496-371DD94D-2EE7-475D-9526-F8EDE3EB3DFEQ35777375-A65233B3-03B8-4392-A454-18283C58FCACQ35814460-31FF52F0-052A-4E68-9932-DD4FD7BC50F7Q35814821-862FB889-2AC8-4867-A2AD-91756F8A0242Q36458495-E2BBDADD-A1E0-4867-B131-9DCCBBA932E8Q36820684-F19DFF79-FFC6-4EBC-A860-465D71B6343FQ36882183-D53AEC92-563A-4948-8872-723CA6DA2BEAQ37031000-49829889-C4B6-4017-BC61-23DD53C4F955Q37200214-BCC3246C-5FEC-4D63-984D-C4345CE1F859Q37461418-5AFA64DF-F950-4804-8AFC-17F4FAE62902Q37918523-9FD3F900-91C1-48AE-A21D-71E4D1906989Q39389842-665152DA-0066-4A5E-8C75-4E57ACC3D1C1Q39505195-8ECDD9E9-E6B1-4157-8976-9BE7D0B6EE08Q40106859-2AD307F1-8C98-4674-8103-0C7C8F170B12Q40640140-8F1DD060-E31C-4B8A-A5DA-7B9885F3220CQ41413714-1EE8EF88-70FA-45D1-9080-E4A069A81C39Q42082584-BE1EA93B-1F35-440F-88F2-E6636070381AQ42410760-B6AABAA1-16EF-4A1F-AF0C-6FC00EAF04D6Q43478176-AC50959F-6901-4751-A6D2-2CEA041E3713Q45730070-E909EA02-365E-4E25-BC8C-04401CFEA2B2Q45882286-6163BA34-F9BF-4EE7-992B-130102BC9391Q46468770-4A6E7D08-ED73-492F-ADBB-5926C08301ECQ47358606-43F43633-88B2-4E95-A318-B36D839F181BQ52469415-03822967-78AE-4439-8C4A-38CEF1995AB0Q53349485-F27CE2D6-34D3-40CC-9E71-A05D0F13B33AQ54969538-B68CE577-EE7D-45B6-BDB3-4B1DF58E23BD
P2860
Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene therapy progress and pros ...... limb and myocardial ischemia.
@ast
Gene therapy progress and pros ...... limb and myocardial ischemia.
@en
type
label
Gene therapy progress and pros ...... limb and myocardial ischemia.
@ast
Gene therapy progress and pros ...... limb and myocardial ischemia.
@en
prefLabel
Gene therapy progress and pros ...... limb and myocardial ischemia.
@ast
Gene therapy progress and pros ...... limb and myocardial ischemia.
@en
P2093
P2860
P356
P1433
P1476
Gene therapy progress and pros ...... limb and myocardial ischemia.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301969
P577
2003-02-01T00:00:00Z